is semaglutide the same as tripeptide CagriSema vs Tirzepatide vs Retatrutide: Comparing Next-Generation Metabolic Peptides Decoding GLP-1 Weight Loss Medications

This guide covers everything from the hard clinical numbers to the indirect ways tirzepatide might affect urinary health, along with proven prevention strategies and clear guidance on when to seek medical attention

Do not administration by the intravenous route

Those treated with tirzepatide had an average weight loss of 15% to 20% of their starting body weight over 72 weeks (about 16.5 months)

The mean reduction in body weight at 48 weeks was 24.2% in the 12-mg group the largest reduction observed to date in a Phase 2 trial of an anti-obesity medication. Jastreboff et al., New England Journal of Medicine, 2023 Beyond weight loss, retatrutide produced a result that surprised researchers: dramatic reductions in liver fat